Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles.
A retrospective study was conducted in a private infertility centre to evaluate the rate of complications in a large oocyte donation programme. A total of 4052 oocyte retrievals were performed between January 2001 and October 2007. Altogether, 1238 cycles (30.6%) were stimulated with the use of gonadotrophin-releasing hormone (GnRH) agonists and in 2814 cycles (69.4%) the GnRH antagonist protocol was used. The GnRH antagonist treated cycles were triggered with human chorionic gonadotrophin (HCG) or a GnRH agonist in 1295 and 1519 cycles, respectively. Complications related to oocyte retrieval occurred in 17 patients (0.42%) (intra-abdominal bleeding: n = 14, severe pain: n = 2, ovarian torsion: n = 1). Fourteen of these were hospitalized (0.35%) and six donors (0.15%) required surgical intervention. Pelvic infections, injury to pelvic structures or anaesthesiological complications were not observed in this series. Moderate/severe ovarian hyperstimulation syndrome (OHSS) occurred in 22 donors; 11 required hospital admission and 11 were managed on an outpatient basis. All cases were related to HCG triggering (0.87%). Serious complications related to oocyte retrieval occurred at a low rate in healthy young donors. The risk of OHSS can be substantially reduced by specific stimulation protocols, which include GnRH agonist triggering. Prospective oocyte donors should be adequately counselled about the risks related to egg donation.
Bodri
Daniel
D
Clínica EUGIN, Calle Entença 293-295, 08029 Barcelona, Spain. dbodri@telefonica.net
Guillén
Juan José
JJ
Polo
Ana
A
Trullenque
Marta
M
Esteve
Carolina
C
Coll
Oriol
O
D000007:Abdominal Injuries / Q000453:epidemiology / Q000209:etiology; D015746:Abdominal Pain / Q000453:epidemiology / Q000209:etiology; D000328:Adult; D005260:Female; D005500:Follow-Up Studies; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists / Q000494:pharmacology; D006470:Hemorrhage / Q000453:epidemiology / Q000209:etiology; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D054315:Oocyte Retrieval / Q000009:adverse effects* / Q000379:methods; D010049:Ovarian Diseases / Q000453:epidemiology / Q000209:etiology; D016471:Ovarian Hyperstimulation Syndrome / Q000139:chemically induced; D010062:Ovulation Induction / Q000009:adverse effects* / Q000379:methods; D012189:Retrospective Studies; D014019:Tissue Donors / Q000706:statistics & numerical data; D054159:Torsion, Mechanical; D018084:Ultrasonography, Interventional / Q000009:adverse effects
D007987:Gonadotropin-Releasing Hormone